136 related articles for article (PubMed ID: 36751313)
1. SH2 domain-containing protein tyrosine phosphatase-2 is enriched in eyelid specimens of rosacea.
Chebolu A; Ramos RB; Arunachalam T; Adam AP; Wladis EJ
Skin Health Dis; 2023 Feb; 3(1):e190. PubMed ID: 36751313
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Factor Kappa-B Is Enriched in Eyelid Specimens of Rosacea: Implications for Pathogenesis and Therapy.
Wladis EJ; Lau KW; Adam AP
Am J Ophthalmol; 2019 May; 201():72-81. PubMed ID: 30703356
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation factor 88 expression in eyelid specimens of rosacea.
Wladis EJ; Arunachalam T; LaJoie JE; Lau KW; Adam AP
Orbit; 2022 Jun; 41(3):329-334. PubMed ID: 33789561
[TBL] [Abstract][Full Text] [Related]
4. Activation of p38 and Erk Mitogen-Activated Protein Kinases Signaling in Ocular Rosacea.
Wladis EJ; Swamy S; Herrmann A; Yang J; Carlson JA; Adam AP
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):843-848. PubMed ID: 28170535
[TBL] [Abstract][Full Text] [Related]
5. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemia.
Müller PJ; Rigbolt KT; Paterok D; Piehler J; Vanselow J; Lasonder E; Andersen JS; Schaper F; Sobota RM
J Proteomics; 2013 Jun; 84():132-47. PubMed ID: 23584145
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.
Wang Q; Zhao WC; Fu XQ; Zheng QC
Front Chem; 2020; 8():597495. PubMed ID: 33330386
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors and vascular markers in ocular rosacea.
Wladis EJ; Carlson JA; Wang MS; Bhoiwala DP; Adam AP
Ophthalmic Plast Reconstr Surg; 2013; 29(4):290-3. PubMed ID: 23839635
[TBL] [Abstract][Full Text] [Related]
9. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T
Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110
[TBL] [Abstract][Full Text] [Related]
10. Molecular biologic assessment of cutaneous specimens of ocular rosacea.
Wladis EJ; Iglesias BV; Adam AP; Gosselin EJ
Ophthalmic Plast Reconstr Surg; 2012; 28(4):246-50. PubMed ID: 22617640
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.
Cunnick JM; Mei L; Doupnik CA; Wu J
J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411
[TBL] [Abstract][Full Text] [Related]
12. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2.
Bonetti D; Troilo F; Toto A; Travaglini-Allocatelli C; Brunori M; Gianni S
J Phys Chem B; 2018 Dec; 122(49):11108-11114. PubMed ID: 30047735
[TBL] [Abstract][Full Text] [Related]
14. Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins.
Hayashi T; Senda M; Suzuki N; Nishikawa H; Ben C; Tang C; Nagase L; Inoue K; Senda T; Hatakeyama M
Cell Rep; 2017 Sep; 20(12):2876-2890. PubMed ID: 28930683
[TBL] [Abstract][Full Text] [Related]
15. SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function.
Chichger H; Braza J; Duong H; Harrington EO
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):695-707. PubMed ID: 25317600
[TBL] [Abstract][Full Text] [Related]
16. Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells.
Adachi M; Iwaki H; Shindoh M; Akao Y; Hachiya T; Ikeda M; Hinoda Y; Imai K
Virchows Arch; 1997 Apr; 430(4):321-5. PubMed ID: 9134043
[TBL] [Abstract][Full Text] [Related]
17. Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase.
Darian E; Guvench O; Yu B; Qu CK; MacKerell AD
Proteins; 2011 May; 79(5):1573-88. PubMed ID: 21365683
[TBL] [Abstract][Full Text] [Related]
18. [The role of protein tyrosine phosphatases Shp-2 involved in the formation of the neuromuscular junction].
Zhao XT; Zhang Z
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1052-6. PubMed ID: 16784710
[TBL] [Abstract][Full Text] [Related]
19. Paediatric ocular rosacea: diagnosis and management with an eyelid-warming device and topical azithromycin 1.5.
Brémond-Gignac D; Navel V; Doan S; Chiambaretta F
J Fr Ophtalmol; 2022 Dec; 45(10):1150-1159. PubMed ID: 36319524
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study.
Bellacchio E
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
